Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
C$2.85
-0.7%
C$2.86
C$1.50
C$5.00
C$696.84M2.98,843 shs851 shs
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$0.26
-3.8%
C$0.26
C$0.15
C$0.53
C$52.28MN/A644,760 shs384,329 shs
Promis Neurosciences stock logo
PMN
Promis Neurosciences
$0.77
-0.6%
$0.56
$0.38
$1.59
$25.06M-0.0521.42 million shs582,691 shs
Resverlogix Corp. stock logo
RVX
Resverlogix
C$0.10
+11.1%
C$0.07
C$0.04
C$0.30
C$19.79M0.71112,881 shs284,726 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
0.00%+10.47%-16.18%+58.33%-22.97%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
0.00%0.00%0.00%0.00%0.00%
Promis Neurosciences stock logo
PMN
Promis Neurosciences
0.00%-22.30%+65.55%+19.77%-46.59%
Resverlogix Corp. stock logo
RVX
Resverlogix
0.00%-25.93%+100.00%+185.71%+100.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
N/AN/AN/AN/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Promis Neurosciences stock logo
PMN
Promis Neurosciences
2.2747 of 5 stars
3.52.00.00.02.90.80.6
Resverlogix Corp. stock logo
RVX
Resverlogix
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
0.00
N/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
0.00
N/AN/AN/A
Promis Neurosciences stock logo
PMN
Promis Neurosciences
3.00
Buy$4.33465.34% Upside
Resverlogix Corp. stock logo
RVX
Resverlogix
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest PMN, BU, EMH, and RVX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/21/2025
Promis Neurosciences stock logo
PMN
Promis Neurosciences
Leede Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeModerate Buy
7/14/2025
Promis Neurosciences stock logo
PMN
Promis Neurosciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$4.00
7/14/2025
Promis Neurosciences stock logo
PMN
Promis Neurosciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$4.00
5/12/2025
Promis Neurosciences stock logo
PMN
Promis Neurosciences
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$3.00
(Data available from 8/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
C$724.40K961.96C$0.07 per share39.00C$0.02 per share116.08
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64
Promis Neurosciences stock logo
PMN
Promis Neurosciences
N/AN/AN/AN/A$0.50 per shareN/A
Resverlogix Corp. stock logo
RVX
Resverlogix
N/AN/AC$0.00 per share132.50C($0.23) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
-C$12.74M-C$0.06N/AN/A-1,758.62%-185.21%-39.22%N/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A-C$0.70N/AN/AN/AN/AN/AN/A
Promis Neurosciences stock logo
PMN
Promis Neurosciences
$2.78M-$0.05N/AN/AN/AN/A-186.19%-98.56%8/6/2025 (Estimated)
Resverlogix Corp. stock logo
RVX
Resverlogix
-C$2.81M-C$0.02N/AN/AN/A6.06%-34.90%N/A

Latest PMN, BU, EMH, and RVX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Promis Neurosciences stock logo
PMN
Promis Neurosciences
-$0.22N/AN/AN/AN/AN/A
5/12/2025Q1 2025
Promis Neurosciences stock logo
PMN
Promis Neurosciences
-$0.14-$0.21-$0.07-$0.21N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
N/A4.45%N/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/A
Promis Neurosciences stock logo
PMN
Promis Neurosciences
N/AN/AN/AN/AN/A
Resverlogix Corp. stock logo
RVX
Resverlogix
N/A7.02%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
187.90
5.63
1.71
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
35.45
2.97
2.61
Promis Neurosciences stock logo
PMN
Promis Neurosciences
N/A
3.36
3.36
Resverlogix Corp. stock logo
RVX
Resverlogix
-10.95
0.13
0.04

Institutional Ownership

CompanyInstitutional Ownership
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
0.21%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A
Promis Neurosciences stock logo
PMN
Promis Neurosciences
50.13%
Resverlogix Corp. stock logo
RVX
Resverlogix
N/A

Insider Ownership

CompanyInsider Ownership
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
28.06%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A
Promis Neurosciences stock logo
PMN
Promis Neurosciences
6.11%
Resverlogix Corp. stock logo
RVX
Resverlogix
42.66%
CompanyEmployeesShares OutstandingFree FloatOptionable
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
20244.51 millionN/ANot Optionable
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
161205.03 millionN/ANot Optionable
Promis Neurosciences stock logo
PMN
Promis Neurosciences
532.69 million30.69 millionNot Optionable
Resverlogix Corp. stock logo
RVX
Resverlogix
19197.94 millionN/ANot Optionable

Recent News About These Companies

Resverlogix Corp. (RVXCF)
Closing Bell: Resverlogix Corp up on Tuesday (RVX)
Closing Bell: Resverlogix Corp flat on Wednesday (RVX)
Resverlogix Corp. (RVX.TO)
Resverlogix Announces Change to Its Board of Directors
Closing Bell: Resverlogix Corp flat on Tuesday (RVX)
Resverlogix Corp. (RVX) Earnings Dates & Reports
Resverlogix Corp RVXCF
Resverlogix Corp RVX

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Burcon NutraScience stock logo

Burcon NutraScience TSE:BU

C$2.85 -0.02 (-0.70%)
As of 08/1/2025 10:15 AM Eastern

Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company offers Peazazz and Peazac, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products. It provides Puratein, a canola protein isolate for use in meat alternatives, such as burgers, sausages, and nutrition bars; Supertein, a canola protein that is a light-colored powder for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows and ready-to-mix beverages, whipped toppings, and plant-based bars; and Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods. In addition, the company offers Nutratein-PS, a blend of Peazazz pea protein and Supertein canola protein; Nutratein-TZ, a blend of Peazac pea protein and Puratein canola protein; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and non-beverage plant-based products. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. The company was incorporated in 1998 and is headquartered in Vancouver, Canada.

Emerald Health Therapeutics stock logo

Emerald Health Therapeutics CVE:EMH

C$0.26 -0.01 (-3.77%)
As of 04/26/2021

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Promis Neurosciences stock logo

Promis Neurosciences NASDAQ:PMN

$0.77 0.00 (-0.60%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$0.76 -0.01 (-0.72%)
As of 08/1/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Resverlogix stock logo

Resverlogix TSE:RVX

C$0.10 +0.01 (+11.11%)
As of 08/1/2025 03:54 PM Eastern

Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.